Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing a combination of THP-00101, THP-00102, and THP-00103 for type 2 diabetes mellitus with essential hypertension; currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • THP-00101
  • THP-00102
  • THP-00103

Snippet

Sponsor: THPharm Corp. | Conditions: Type 2 Diabetes, Hypertension | Phase 3 | Status: RECRUITING